Eugene Braunwald – författare

The leading source of reliable cardiology information for practitioners and trainees worldwide, Braunwald’s Heart Disease, 13th Edition, remains the most trusted reference in the field. Written and edited by global experts, this award-winning, two-volume text offers outstanding coverage of new drugs, new guidelines, more powerful imaging modalities, and recent developments in precision medicine that continue to advance the practice of cardiovascular medicine and improve patients’ quality of life. This unparalleled multimedia reference is an essential resource for today’s cardiologists, cardiology fellows, and those studying for certification or recertification.

**Selected for Doody’s Core Titles® 2024 with "Essential Purchase" designation in Cardiology**Current, comprehensive, and evidence-based Braunwald’s Heart Disease remains the most trusted reference in the field and the leading source of reliable cardiology information for practitioners and trainees worldwide. The fully updated 12th Edition continues the tradition of excellence with dependable, state-of-the-art coverage of new drugs, new guidelines, more powerful imaging modalities, and recent developments in precision medicine that continue to change and advance the practice of cardiovascular medicine. Written and edited by global experts in the field, this award-winning text is an unparalleled multimedia reference for every aspect of this complex and fast-changing area.Offers balanced, dependable content on rapidly changing clinical science, clinical and translational research, and evidence-based medicine.Includes 76 new contributing authors and 14 new chapters that cover Artificial intelligence in Cardiovascular Medicine; Wearables; Influenza, Pandemics, COVID-19, and Cardiovascular Disease; Tobacco and Nicotine Products in Cardiovascular Disease; Cardiac Amyloidosis; Impact of the Environment on Cardiovascular Health, and more.Features a new introductory chapter Cardiovascular Disease: Past, Present, and Future by Eugene Braunwald, MD, offering his unique, visionary approach to the field of cardiology. Dr. Braunwald also curates the extensive, bimonthly online updates that include "Hot Off the Press" (with links to Practice Update) and "Late-Breaking Clinical Trials".Provides cutting-edge coverage of key topics such as proteomics and metabolomics, TAVR, diabetocardiology, and cardio-oncology.Contains 1,850 high-quality illustrations, radiographic images, algorithms, and charts, and provides access to 215 videos called out with icons in the print version.Highlights the latest AHA, ACC, and ESC guidelines to clearly summarize diagnostic criteria and clinical implications.Provides tightly edited, focused content for quick, dependable reference. Flexible format options include either one or two volumes in print, as well as a searchable eBook with ongoing updates.Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

Current, comprehensive, and evidence-based Braunwald's Heart Disease remains the most trusted reference in the field and the leading source of reliable cardiology information for practitioners and trainees worldwide. The fully updated 12th Edition continues the tradition of excellence with dependable, state-of-the-art coverage of new drugs, new guidelines, more powerful imaging modalities, and recent developments in precision medicine that continue to change and advance the practice of cardiovascular medicine. Written and edited by global experts in the field, this award-winning text is an unparalleled multimedia reference for every aspect of this complex and fast-changing area.Offers balanced, dependable content on rapidly changing clinical science, clinical and translational research, and evidence-based medicine.Includes 76 new contributing authors and 14 new chapters that cover Artificial intelligence in Cardiovascular Medicine; Wearables; Influenza, Pandemics, COVID-19, and Cardiovascular Disease; Tobacco and Nicotine Products in Cardiovascular Disease; Cardiac Amyloidosis; Impact of the Environment on Cardiovascular Health, and more.Features a new introductory chapter Cardiovascular Disease: Past, Present, and Future by Eugene Braunwald, MD, offering his unique, visionary approach to the field of cardiology. Dr. Braunwald also curates the extensive, bimonthly online updates that include "Hot Off the Press" (with links to Practice Update) and "Late-Breaking Clinical Trials".Provides cutting-edge coverage of key topics such as proteomics and metabolomics, TAVR, diabetocardiology, and cardio-oncology.Contains 1,850 high-quality illustrations, radiographic images, algorithms, and charts, and provides access to 215 videos called out with icons in the print version.Highlights the latest AHA, ACC, and ESC guidelines to clearly summarize diagnostic criteria and clinical implications.Provides tightly edited, focused content for quick, dependable reference. Flexible format options include either one or two volumes in print, as well as a searchable eBook with ongoing updates.Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

The leading source of reliable cardiology information for practitioners and trainees worldwide, Braunwald’s Heart Disease, 13th Edition, remains the most trusted reference in the field. Written and edited by global experts, this award-winning, two-volume text offers outstanding coverage of new drugs, new guidelines, more powerful imaging modalities, and recent developments in precision medicine that continue to advance the practice of cardiovascular medicine and improve patients’ quality of life. This unparalleled multimedia reference is an essential resource for today’s cardiologists, cardiology fellows, and those studying for certification or recertification.Offers balanced, dependable content on rapidly changing clinical science, clinical and translational research, and evidence-based medicine, as well as detailed explanations of each disease entity and differential diagnosesCovers key topics such as obesity: lifestyle, medical, and surgical management; COVID-19 and influenza and the cardiovascular system; TAVR; diabetocardiology; cardio-oncology; and moreIncludes an updated chapter dedicated to artificial intelligence and wearables [RM1] in cardiovascular medicine, as well as fully revised AI sections in all relevant chaptersFeatures extensive, bimonthly online updates curated by Eugene Braunwald, MD, that include "Hot Off the Press" and "Late-Breaking Clinical Trials"Provides newly formatted guidelines that summarize diagnostic criteria and clinical implications-short summary boxes in print and key flowcharts, algorithms, and tables from the formal society guidelines with links in the eBookIncludes new key points boxes in select chapters that highlight important take-away messagesContains 1,850 high-quality illustrations, radiographic images, algorithms, and charts, and provides access to 200+ videos called out with icons in the print version; new videos cover timely topics such as physical examination in the era of telemedicineOffers flexible format options for quick, dependable reference: choose from either one or two volumes in print, as well as a searchable eBook with ongoing updatesAn eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud

Biomarkers - which may be enzymes, hormones, biologic substances, or other markers of cardiac stress and malfunction - appear to have growing clinical importance in heart failure. Many biomarkers appear to provide important information about the cause of heart failure or the identification of those at risk for heart failure or appear to be useful in risk stratification, in the diagnosis of heart failure, or in monitoring therapy. This issue discusses the current and potential future role of biomarkers and includes articles that explore individual biomarkers in depth.

A critical phase in coronary heart disease, unstable angina, is thoroughly discussed in contributions by well-known experts. Since myocardial infarction still belongs to the main causes of death, this topic is highly relevant for the present research and possible future treatment of coronary heart disease. The major recent advances made in the pathophysiology, diagnosis and therapy of unstable angina are reported in depth.